Roivant Sciences Ltd. (ROIV) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Roivant Sciences Ltd. (ROIV) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How ROIV Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $8.3M | 44% | -6235.7% | -$299.8M | -$758.6M | -14% |
| FY 2024 | $29.1M | 44% | -3453.3% | -$172.0M | -$844.0M | -23.9% |
| FY 2023 | $32.7M | 44% | 13746.9% | $4.35B | -$766.7M | 39.5% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring ROIV)
- ✓Live walkthrough of ROIV's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
ROIV Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -65.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ROIV today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ROIV. Explore sector supply chains on /butterfly.
ROIV Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Roivant Sciences Ltd. (ROIV)?
In FY 2025 (10-K), ROIV converted $8.3M of revenue into a 44% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).